Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Targeting the undruggable: menin inhibitors ante portas

Acute lymphoblastic leukemia - Wikipedia

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

The promise of chromatin research to advance precision medicine - EpiCypher

Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Biomedicines, Free Full-Text

Novel and Emerging Treatment Strategies for Acute Myeloid Leukemia in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 7.5 (2020)

Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation - ScienceDirect

Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer, Cancer Cell International

Frontiers Molecular Approaches to Treating Pediatric Leukemias

City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias

The Menin/KMT2A interaction is a therapeutic target in human MN1

Frontiers Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia